140 related articles for article (PubMed ID: 9558006)
1. Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells.
White CM; Martin BK; Lee LF; Haskill JS; Ting JP
Cancer Immunol Immunother; 1998 Apr; 46(2):104-12. PubMed ID: 9558006
[TBL] [Abstract][Full Text] [Related]
2. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer.
Lee LF; Schuerer-Maly CC; Lofquist AK; van Haaften-Day C; Ting JP; White CM; Martin BK; Haskill JS
Cancer Res; 1996 Mar; 56(6):1303-8. PubMed ID: 8640818
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation.
Mullins DW; Koci MD; Burger CJ; Elgert KD
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):473-92. PubMed ID: 9805229
[TBL] [Abstract][Full Text] [Related]
4. In vitro exposure to paclitaxel modulates integrin expression by human T lymphocytes and inhibits T cell adhesion to breast carcinoma cells.
Bhan V; Mader JS; Hoskin DW
Oncol Rep; 2004 Apr; 11(4):893-7. PubMed ID: 15010891
[TBL] [Abstract][Full Text] [Related]
5. Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493).
Björk L; Tracey KJ; Ulrich P; Bianchi M; Cohen PS; Akerlund K; Fehniger TE; Andersson U; Andersson J
J Infect Dis; 1997 Nov; 176(5):1303-12. PubMed ID: 9359732
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells.
Napoleone E; Zurlo F; Latella MC; Amore C; Di Santo A; Iacoviello L; Donati MB; Lorenzet R
Eur J Cancer; 2009 Feb; 45(3):470-7. PubMed ID: 19046877
[TBL] [Abstract][Full Text] [Related]
7. The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: synergy with interleukin-2 and modulation of interleukin-2Rgamma chain expression.
Bosco MC; Rottschafer S; Taylor LS; Ortaldo JR; Longo DL; Espinoza-Delgado I
Blood; 1997 May; 89(9):3402-11. PubMed ID: 9129048
[TBL] [Abstract][Full Text] [Related]
8. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells.
Watson JM; Kingston DG; Chordia MD; Chaudhary AG; Rinehart CA; Haskill JS
Cancer Chemother Pharmacol; 1998; 41(5):391-7. PubMed ID: 9523735
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
Mullins DW; Burger CJ; Elgert KD
J Immunol; 1999 Jun; 162(11):6811-8. PubMed ID: 10352302
[TBL] [Abstract][Full Text] [Related]
10. Taxol-induced ceramide generation and apoptosis in human breast cancer cells.
Charles AG; Han TY; Liu YY; Hansen N; Giuliano AE; Cabot MC
Cancer Chemother Pharmacol; 2001 May; 47(5):444-50. PubMed ID: 11391861
[TBL] [Abstract][Full Text] [Related]
11. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines.
Zaks-Zilberman M; Zaks TZ; Vogel SN
Cytokine; 2001 Aug; 15(3):156-65. PubMed ID: 11554785
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes.
Alderson MR; Tough TW; Ziegler SF; Grabstein KH
J Exp Med; 1991 Apr; 173(4):923-30. PubMed ID: 2007858
[TBL] [Abstract][Full Text] [Related]
13. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.
Tsavaris N; Kosmas C; Vadiaka M; Kanelopoulos P; Boulamatsis D
Br J Cancer; 2002 Jul; 87(1):21-7. PubMed ID: 12085250
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
Ueno NT; Yu D; Hung MC
Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
Jang CH; Choi JH; Byun MS; Jue DM
Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
Duan Z; Lamendola DE; Penson RT; Kronish KM; Seiden MV
Cytokine; 2002 Mar; 17(5):234-42. PubMed ID: 12027404
[TBL] [Abstract][Full Text] [Related]
17. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
Gooch JL; Lee AV; Yee D
Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).
Ruiz de Souza V; Carreno MP; Kaveri SV; Ledur A; Sadeghi H; Cavaillon JM; Kazatchkine MD; Haeffner-Cavaillon N
Eur J Immunol; 1995 May; 25(5):1267-73. PubMed ID: 7774630
[TBL] [Abstract][Full Text] [Related]
20. Direct contact with stimulated T cells induces the expression of IL-1beta and IL-1 receptor antagonist in human monocytes. Involvement of serine/threonine phosphatases in differential regulation.
Vey E; Dayer JM; Burger D
Cytokine; 1997 Jul; 9(7):480-7. PubMed ID: 9237810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
